PRESS

The talk on the town.

Our AI-driven voice analysis is making a real impact on mental healthcare.
Read what the press has to say about Kintsugi.
December 8, 2022
The American Genius

This App Looks to Change the Current Mental Health Crisis

Kintsugi was featured in American Genius for leveraging voice biomarkers to transform the quality and reach of mental health support everywhere.
Read Full Article
December 7, 2022
Galen Growth

HealthTech 250: The Most Promising Early-stage Digital Health Ventures in 2022

Kintsugi has been named to Galen Growth | Global HealthTech Insights HealthTech 250: The Most Promising Early-stage Digital Health Ventures in 2022.
Read Full Article
December 7, 2022
CB Insights

The Digital Health 150: The Most Promising Digital Health Companies of 2022

Kintsugi has been named to CB Insights Top 150 Digital Health Startups in the screening, monitoring, and diagnostics category.
Read Full Article
November 21, 2022
Psychology Today

AI can use your voice to detect depression

Kintsugi was featured in Psychology Today as an AI voice biomarker tool that has the potential to more objectively identify signs of depression than existing mental health screening methods.
Read Full Article
October 21, 2022
Axios

"Voice biomarker" tech analyzes your voice for signs of depression

Kintsugi CEO & Founder, Grace Chang, was featured in Axios, for framing up what voice biomarker technology is and how it can be used to aid clinicians in the identification of medical issues.
Read Full Article